Spruce Biosciences

Spruce Biosciences

Spruce Biosciences

Spruce Biosciences is a clinical-stage biopharmaceutical focused on developing new treatments for rare endocrine disorders.
Founded
2014
Raised
$88M
Follow us
Alexa global traffic share
20 Feb 2020
$88,000,000
Venture capital (Series B)

Spruce Biosciences Raises $88M in Series B Financing

FinSMEs
+1